Viewing Study NCT00504634


Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2026-03-11 @ 12:56 AM
Study NCT ID: NCT00504634
Status: COMPLETED
Last Update Posted: 2011-09-15
First Post: 2007-07-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bortezomib (Velcade) Post Allogenic Peripheral Blood Stem Cell Transplantation for Myeloma
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module